← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2007Last known activity
Jan 1, 2016
Timeline
1960s
- Jul 1, 1966
furosemide— Marketing Organization
1970s
- Aug 17, 1978
calcitriol— NDA Organization
2000s
- Dec 10, 2004
carbamazepine— NDA Secondary Org
- Jan 1, 2007
Validus Pharmaceuticals— Founded
Drugs by trial phase (1 distinct, 4 trials)
Phase 4 (1 own, 0 via acquisition)
Indications
Approved for
- Acromegaly
- Bacteremia
- Bone Diseases, Infectious
- Central Nervous System Infections
- Depression
- Diabetes Mellitus, Type 2
- Endocarditis
- Genital Diseases, Female
- Gonorrhea
- Hyperprolactinemia
- Hypocalcemia
- Hypogonadism
- Hypoparathyroidism
- Infertility
- Infertility, Female
- Intermittent Claudication
- Intraabdominal Infections
- Kidney Failure, Chronic
- Parkinson Disease
- Postoperative Nausea and Vomiting
- Psoriasis
- Respiratory Tract Infections
- Skin Diseases, Bacterial
- Urinary Tract Infections
Studied for
Marketed drugs (16)
Recent trials (4)
- NCT02623504Lead sponsorPhase 4Jan 1, 2016
- NCT00350857Lead sponsorPhase 4Jul 1, 2006
- NCT00150605Lead sponsorPhase 3Feb 1, 2005
- NCT00150553Lead sponsorPhase 3Jan 1, 2005
Details
- Founded
- Parsippany, NJ, US Jan 1, 2007
- Last known activity
- Jan 1, 2016
Designations held
- Priority review